444 related articles for article (PubMed ID: 28882007)
1. Epidemiology of antibiotic resistance in Pseudomonas aeruginosa. Implications for empiric and definitive therapy.
Ruiz-Garbajosa P; Cantón R
Rev Esp Quimioter; 2017 Sep; 30 Suppl 1():8-12. PubMed ID: 28882007
[TBL] [Abstract][Full Text] [Related]
2. The increasing threat of Pseudomonas aeruginosa high-risk clones.
Oliver A; Mulet X; López-Causapé C; Juan C
Drug Resist Updat; 2015; 21-22():41-59. PubMed ID: 26304792
[TBL] [Abstract][Full Text] [Related]
3. Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.
Cabot G; Ocampo-Sosa AA; Domínguez MA; Gago JF; Juan C; Tubau F; Rodríguez C; Moyà B; Peña C; Martínez-Martínez L; Oliver A;
Antimicrob Agents Chemother; 2012 Dec; 56(12):6349-57. PubMed ID: 23045355
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update.
Del Barrio-Tofiño E; López-Causapé C; Oliver A
Int J Antimicrob Agents; 2020 Dec; 56(6):106196. PubMed ID: 33045347
[TBL] [Abstract][Full Text] [Related]
5. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.
Fernández-Barat L; Ferrer M; De Rosa F; Gabarrús A; Esperatti M; Terraneo S; Rinaudo M; Li Bassi G; Torres A
J Infect; 2017 Feb; 74(2):142-152. PubMed ID: 27865895
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa.
Cardozo C; Rico V; Agüero D; Soriano A
Rev Esp Quimioter; 2019 Sep; 32 Suppl 2(Suppl 2):32-34. PubMed ID: 31475807
[TBL] [Abstract][Full Text] [Related]
7. Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China.
Li J; Zou M; Dou Q; Hu Y; Wang H; Yan Q; Liu WE
Ann Clin Microbiol Antimicrob; 2016 May; 15(1):35. PubMed ID: 27215335
[TBL] [Abstract][Full Text] [Related]
8. Multidrug and extensive drug resistance in Pseudomonas aeruginosa clinical isolates from a Portuguese central hospital: 10-year survey.
Pereira SG; Marques M; Pereira J; Cardoso O
Microb Drug Resist; 2015 Apr; 21(2):194-200. PubMed ID: 25372011
[TBL] [Abstract][Full Text] [Related]
9. [Nosocomial infections caused by multiresistant Pseudomonas aeruginosa (carbapenems included): predictive and prognostic factors. A prospective study (2016-2017))].
Hernández A; Yagüe G; García Vázquez E; Simón M; Moreno Parrado L; Canteras M; Gómez J
Rev Esp Quimioter; 2018 Apr; 31(2):123-130. PubMed ID: 29564870
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance in Pseudomonas aeruginosa - Mechanisms, epidemiology and evolution.
Botelho J; Grosso F; Peixe L
Drug Resist Updat; 2019 May; 44():100640. PubMed ID: 31492517
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for hospitalized patients with resistant or multidrug-resistant
Raman G; Avendano EE; Chan J; Merchant S; Puzniak L
Antimicrob Resist Infect Control; 2018; 7():79. PubMed ID: 29997889
[TBL] [Abstract][Full Text] [Related]
12. Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegans Pseudomonas aeruginosa Infection Model.
Sánchez-Diener I; Zamorano L; López-Causapé C; Cabot G; Mulet X; Peña C; Del Campo R; Cantón R; Doménech-Sánchez A; Martínez-Martínez L; Arcos SC; Navas A; Oliver A
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923877
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial spread of class 1 integron-carrying extensively drug-resistant Pseudomonas aeruginosa isolates in a Thai hospital.
Kiddee A; Henghiranyawong K; Yimsabai J; Tiloklurs M; Niumsup PR
Int J Antimicrob Agents; 2013 Oct; 42(4):301-6. PubMed ID: 23845503
[TBL] [Abstract][Full Text] [Related]
14. In vitro interaction of various antibiotic combinations recommended by Chinese consensus statement against carbapenems-resistant Pseudomonas aeruginosa.
Ma W; Li J; Wang D; Yu C; Sun S
Lett Appl Microbiol; 2019 Sep; 69(3):198-203. PubMed ID: 31236975
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections.
Palavutitotai N; Jitmuang A; Tongsai S; Kiratisin P; Angkasekwinai N
PLoS One; 2018; 13(2):e0193431. PubMed ID: 29470531
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
[TBL] [Abstract][Full Text] [Related]
17. The peculiarities of Pseudomonas aeruginosa resistance to antibiotics and prevalence of serogroups.
Gailiene G; Pavilonis A; Kareiviene V
Medicina (Kaunas); 2007; 43(1):36-42. PubMed ID: 17297282
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
Vatcheva-Dobrevska R; Mulet X; Ivanov I; Zamorano L; Dobreva E; Velinov T; Kantardjiev T; Oliver A
Microb Drug Resist; 2013 Oct; 19(5):355-61. PubMed ID: 23600605
[TBL] [Abstract][Full Text] [Related]
19. Intraclonal variations of resistance and phenotype in Pseudomonas aeruginosa epidemic high-risk clone ST308: A key to success within a hospital?
Abdouchakour F; Aujoulat F; Licznar-Fajardo P; Marchandin H; Toubiana M; Parer S; Lotthé A; Jumas-Bilak E
Int J Med Microbiol; 2018 Mar; 308(2):279-289. PubMed ID: 29276044
[TBL] [Abstract][Full Text] [Related]
20. Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting.
Juan C; Gutiérrez O; Oliver A; Ayestarán JI; Borrell N; Pérez JL
Clin Microbiol Infect; 2005 Nov; 11(11):887-92. PubMed ID: 16216103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
